Onyx Scientific, a contract development and manufacturing organization (CDMO) in the small molecule space, has completed the second phase of expansion at its state-of-the-art chemistry, manufacturing, and controls (CMC) facility in Sunderland, UK. The investment increases the facility’s capabilities to provide CMC services and strengthens Onyx’s UK manufacturing capabilities for non-GMP scale-up by more than 50%. The new facility consists of four laboratories (each capable of containing fo...